Nonlinear Association Between Liver Fat Content and Lumbar Bone Mineral Density in Overweight and Obese Individuals: Evidence from a Large-scale Health Screening Data in China

Overview

Journal Endocrine

Date 2025 Jan 27

PMID 39869295

Authors

Ao Liu

Yongbing Sun

Xin Qi

Yang Zhou

Jing Zhou

Zhonglin Li

Xiaoling Wu

Zhi Zou

Xue Lv

Hao Li

Yongli Li

Affiliations

Soon will be listed here.

Abstract

Background: The impact of fatty liver disease on lumbar bone mineral density (BMD) represents an intriguing area of study, particularly in light of established research linking obesity to bone metabolism. However, there remains limited investigation into the correlation between quantifying liver fat content (LFC) and lumbar BMD among overweight and obese populations, particularly within the Chinese demographic. This study aims to accurately quantify LFC and investigate its association with lumbar BMD in overweight or obese individuals.

Methods: This cross-sectional study was conducted at the Health Management Center of Henan Provincial People's Hospital from January 2019 to February 2023, involving 6996 participants with a body mass index (BMI) of 24 kg/m² or higher. LFC and lumbar BMD were assessed using computed tomography. The study utilized one-way ANOVA, subgroup analysis, multifactor regression analysis, smooth curve fitting, and threshold and saturation effect analysis to explore the relationship between LFC and lumbar BMD. Furthermore, inflammatory cell analysis was included to investigate the potential mediating role of inflammatory cells in the association between LFC and lumbar BMD.

Results: After adjusting for confounding variables, multivariate regression analysis revealed a significant negative association between LFC and lumbar BMD (β = -0.323, 95% CI: -0.464 to -0.183, P < 0.001). Particularly, participants in the highest baseline LFC quartile (Q4 group) exhibited a more pronounced negative impact on lumbar BMD compared to those in the lowest quartile (Q1 group) (β = -5.026, 95% CI: -7.040 to -3.012, P < 0.001). Threshold saturation effect analysis identified a turning point in the LFC-BMD relationship (K = 5.4). Below this point, LFC showed a positive correlation with lumbar BMD (β = 0.962, 95% CI: 0.016-1.907, P < 0.05), whereas above it, LFC was significantly negatively correlated with lumbar BMD (β = -0.405, 95% CI: -0.558 to -0.253, P < 0.001). Additionally, mediation analysis indicated that leukocytes and monocytes potentially mediated the association between LFC and lumbar BMD, with mediation ratios of -5.78 and -6.68%, respectively.

Conclusion: Among individuals categorized as overweight or obese, elevated levels of LFC were associated with reduced lumbar BMD, particularly noticeable above a threshold of 5.4%. Additionally, various types of inflammatory cells are presumed to exert a substantial mediating influence on the correlation between LFC and lumbar BMD.

References

Gopinath V . Osteoporosis. Med Clin North Am. 2023; 107(2):213-225. DOI: 10.1016/j.mcna.2022.10.013. View

Arceo-Mendoza R, Camacho P . Postmenopausal Osteoporosis: Latest Guidelines. Endocrinol Metab Clin North Am. 2021; 50(2):167-178. DOI: 10.1016/j.ecl.2021.03.009. View

Wang L, Yu W, Yin X, Cui L, Tang S, Jiang N . Prevalence of Osteoporosis and Fracture in China: The China Osteoporosis Prevalence Study. JAMA Netw Open. 2021; 4(8):e2121106. PMC: 8369359. DOI: 10.1001/jamanetworkopen.2021.21106. View

Yang T, Shen H, Liu A, Dong S, Zhang L, Deng F . A road map for understanding molecular and genetic determinants of osteoporosis. Nat Rev Endocrinol. 2019; 16(2):91-103. PMC: 6980376. DOI: 10.1038/s41574-019-0282-7. View

Targher G, Lonardo A, Rossini M . Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?. J Endocrinol Invest. 2015; 38(8):817-25. DOI: 10.1007/s40618-015-0315-6. View

Lee H, Lee H, Kim E, Kim H, Kim H, Ahn S . Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease. Gut. 2023; 73(3):533-540. DOI: 10.1136/gutjnl-2023-331003. View

Chan W, Chuah K, Rajaram R, Lim L, Ratnasingam J, Vethakkan S . Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review. J Obes Metab Syndr. 2023; 32(3):197-213. PMC: 10583766. DOI: 10.7570/jomes23052. View

Ahn S, Seo D, Kim S, Nam M, Hong S . The relationship between fatty liver index and bone mineral density in Koreans: KNHANES 2010-2011. Osteoporos Int. 2017; 29(1):181-190. DOI: 10.1007/s00198-017-4257-z. View

Kushioka J, Chow S, Toya M, Tsubosaka M, Shen H, Gao Q . Bone regeneration in inflammation with aging and cell-based immunomodulatory therapy. Inflamm Regen. 2023; 43(1):29. PMC: 10210469. DOI: 10.1186/s41232-023-00279-1. View

10.

Russell M, Mendes N, Miller K, Rosen C, Lee H, Klibanski A . Visceral fat is a negative predictor of bone density measures in obese adolescent girls. J Clin Endocrinol Metab. 2010; 95(3):1247-55. PMC: 2841531. DOI: 10.1210/jc.2009-1475. View

11.

Wu Y, Guo Z, Fu X, Wu J, Gao J, Zeng Q . The study protocol for the China Health Big Data (China Biobank) project. Quant Imaging Med Surg. 2019; 9(6):1095-1102. PMC: 6629571. DOI: 10.21037/qims.2019.06.16. View

12.

Groenwold R, White I, Donders A, Carpenter J, Altman D, Moons K . Missing covariate data in clinical research: when and when not to use the missing-indicator method for analysis. CMAJ. 2012; 184(11):1265-9. PMC: 3414599. DOI: 10.1503/cmaj.110977. View

13.

White I, Royston P, Wood A . Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011; 30(4):377-99. DOI: 10.1002/sim.4067. View

14.

Olali A, Shi Q, Hoover D, Bucovsky M, Shane E, Yin M . Bone and fat hormonal crosstalk with antiretroviral initiation. Bone. 2021; 154:116208. PMC: 8671338. DOI: 10.1016/j.bone.2021.116208. View

15.

Yang Y, Li L, Zhang Y, Yang H, Bai J, Lv H . Association Between Coronary Artery Calcium Score and Bone Mineral Density in Type 2 Diabetes Mellitus with Different Visceral Fat Area. Diabetes Metab Syndr Obes. 2022; 15:3949-3960. PMC: 9766512. DOI: 10.2147/DMSO.S392152. View

16.

Xia M, Lin H, Yan H, Bian H, Chang X, Zhang L . The association of liver fat content and serum alanine aminotransferase with bone mineral density in middle-aged and elderly Chinese men and postmenopausal women. J Transl Med. 2016; 14:11. PMC: 4721203. DOI: 10.1186/s12967-016-0766-3. View

17.

Labayen I, Cadenas-Sanchez C, Idoate F, Medrano M, Tobalina I, Villanueva A . Liver Fat, Bone Marrow Adipose Tissue, and Bone Mineral Density in Children With Overweight. J Clin Endocrinol Metab. 2023; 109(1):e253-e258. DOI: 10.1210/clinem/dgad429. View

18.

Du J, Ma Y, Lang H, Huang C, Zhang X . The association of nonalcoholic fatty liver disease with bone mineral density in type 2 diabetes. Eur J Med Res. 2022; 27(1):143. PMC: 9358869. DOI: 10.1186/s40001-022-00775-z. View

19.

Li B, Simon T, Wang N, Chung R, Corey K, Dichtel L . Association Between Liver Fat and Bone Density is Confounded by General and Visceral Adiposity in a Community-Based Cohort. Obesity (Silver Spring). 2021; 29(3):595-600. PMC: 7904629. DOI: 10.1002/oby.23100. View

20.

Liu H, Li D, Zhang Y, Li M . Inflammation, mesenchymal stem cells and bone regeneration. Histochem Cell Biol. 2018; 149(4):393-404. DOI: 10.1007/s00418-018-1643-3. View